Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-16-005969
Filing Date
2016-04-22
Accepted
2016-04-22 16:56:01
Documents
57
Period of Report
2015-08-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT panther_10q-083115.htm 10-Q 322923
2 CERTIFICATION panther_10q-ex3101.htm EX-31.1 7329
3 CERTIFICATION panther_10q-ex3102.htm EX-31.2 7371
4 CERTIFICATION panther_10q-ex3201.htm EX-32.1 2766
5 CERTIFICATION panther_10q-ex3202.htm EX-32.2 2751
  Complete submission text file 0001019687-16-005969.txt   2093094

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pbya-20150831.xml EX-101.INS 335256
7 XBRL SCHEMA FILE pbya-20150831.xsd EX-101.SCH 28268
8 XBRL CALCULATION FILE pbya-20150831_cal.xml EX-101.CAL 43895
9 XBRL DEFINITION FILE pbya-20150831_def.xml EX-101.DEF 54434
10 XBRL LABEL FILE pbya-20150831_lab.xml EX-101.LAB 166378
11 XBRL PRESENTATION FILE pbya-20150831_pre.xml EX-101.PRE 140665
Mailing Address 888 PROSPECT STREET LA JOLLA CA 92037
Business Address 888 PROSPECT STREET LA JOLLA CA 92037 (858) 263-2744
PANTHER BIOTECHNOLOGY, INC. (Filer) CIK: 0001530981 (see all company filings)

EIN.: 331221758 | State of Incorp.: NV | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-55074 | Film No.: 161587152
SIC: 8700 Services-Engineering, Accounting, Research, Management